
Depression often reflects broader disruptions in inflammation, cellular energy, and systemic balance. Essential fatty acids (EFAs)—including omega-3s EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), along with GLA from borage oil—play a central role in supporting mood, cognitive function, and overall systemic health.
Supporting Mood, Cognition, & Systemic Health
EFAs support multiple pathways in the body and brain. They integrate into cell membranes, help regulate neurotransmission, balance inflammation, and support cellular signaling. When levels of these fatty acids are low, neuronal function and mood regulation can be compromised, potentially increasing vulnerability to depressive symptoms.
Research Connecting EFAs & Depression
Recent research highlights the therapeutic potential of omega-3 PUFAs in depression:
- A 2025 review found that higher doses of EPA (greater than 1 g/day) improved depressive symptoms, particularly in populations with high inflammation and comorbid cardiovascular conditions. These improvements were connected to reduced inflammation and improved balance in key signaling fats, along with measurable benefits for mood, thinking, and brain connectivity.
- A case-control study on short-chain fatty acids showed that higher baseline levels of butyrate, an omega-3–linked metabolite, predicted greater likelihood of depression remission over six months. This suggests a link between fatty acid metabolism and recovery from depressive episodes.
- In late-life depression, a 52-week randomized trial found that supplementation with EPA and DHA significantly reduced the risk of depressive recurrence (Cheng et al., 2025).
- A 2025 meta-analysis further showed that daily intake of 1000–1500 mg of omega-3 PUFAs (EPA/DHA) over the course of eight weeks may benefit individuals with mild to moderate depression, by supporting mood and overall systemic health.
Mechanistic Insights: How EFAs Support Mental Health
EFAs support emotional and cognitive function through multiple mechanisms:
- Neurotransmission and cell signaling: EPA and DHA integrate into neuronal membranes, modulating neurotransmitter function and synaptic plasticity.
- Anti-inflammatory effects: Omega-3 PUFAs reduce pro-inflammatory cytokines and promote anti-inflammatory lipid mediators, helping balance mood and cognitive function.
- Energy and systemic balance: EFAs support mitochondrial function and energy metabolism, promoting neuronal and systemic resilience.
Unique Bioavailability of EFA Essentials
Pure Encapsulations EFA Essentials combines highly absorbable triglyceride-form fish oil with cold-pressed borage oil to maximize benefits for mood, cognition, and overall systemic health. The fish oil is carefully purified and tested to remove heavy metals, dioxins, PCBs, and other contaminants, while the borage oil is cold-pressed to preserve its natural GLA content. A blend of natural antioxidants—including rosemary extract, mixed tocopherols, and ascorbyl palmitate—protects the oils from oxidation, ensuring stability and effective absorption in the body. This thoughtfully designed formulation supports the biochemical pathways underlying emotional resilience, as well as joint, skin, and eye health.
Targeted Nutritional Support
Each softgel delivers:
- EPA/DHA (from fish oil): Supports mood regulation, cognitive function, and anti-inflammatory pathways.
- GLA (from borage oil): Supports skin hydration, joint health, and ocular moisture.
Together, these fatty acids help maintain the biochemical foundation of resilience, supporting systemic, cognitive, and emotional health.
In Short
Depression is often linked to systemic imbalances, including inflammation, energy dysregulation, and impaired cellular signaling. Essential fatty acids are fundamental to these pathways, and evidence shows that adequate intake may support mood, cognition, and overall systemic health. Pure Encapsulations EFA Essentials delivers these critical nutrients in a highly bioavailable and purified form, helping replenish and sustain fatty acid reserves that underlie mental and systemic well-being.
Discover a personalized, whole-body plan to find and fix the root causes of your depression in Dr. Greenblatt’s newest book, Finally Hopeful.
References
- Dyall SC, Malau IA, Su KP. Omega-3 polyunsaturated fatty acids in depression: insights from recent clinical trials. Curr Opin Clin Nutr Metab Care. 2025 Mar 1;28(2):66-74. doi: 10.1097/MCO.0000000000001077. Epub 2024 Sep 23. PMID: 39912390.
- Schiweck C, Dalile B, Balliet A, et al. Circulating short chain fatty acids are associated with depression severity and predict remission from major depressive disorder. Brain Behav Immun Health. 2025 Jul 19;48:101070. doi: 10.1016/j.bbih.2025.101070. PMID: 40761299; PMCID: PMC12320157.
- Cheng YC, Chen WY, Lin C, et al. The N-3 polyunsaturated fatty acids supplementation to prevent depression recurrence in patients with late-life depression: A 52-week double-blind, placebo-controlled trial. J Affect Disord. 2025 Jan 15;369:8-15. doi: 10.1016/j.jad.2024.09.129. Epub 2024 Sep 19. PMID: 39306009.
- Kong L, Zhang Q, Wang H, et al. Exploration of the optimized portrait of omega-3 polyunsaturated fatty acids in treating depression: A meta-analysis of randomized-controlled trials. J Affect Disord. 2025 Jun 15;379:489-501. doi: 10.1016/j.jad.2025.03.006. Epub 2025 Mar 4. PMID: 40049535.